Overview
- 37 inspections across 37 sites are on record.
- 119 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-07-16.
At a glance
Inspections
37
Sites
37
Observations
119
Career since
Apr 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Ocean Group Inc. | 16 Jul 2025 | Foods & Cosmetics | On file |
| Vantive Manufacturing Pte. Ltd. | 13 Dec 2024 | Human Drugs | On file |
| Vantive Manufacturing (Thailand) Company | 3 Dec 2024 | Human Drugs | On file |
| Nephron SC, LLC | 9 Feb 2024 | Human Drugs | On file |
| Takeda Pharmaceutical Company Limited | 6 Nov 2023 | Human Drugs | On file |
Sites inspected
Ocean Group Inc.Los Angeles, United States1 insp.
Vantive Manufacturing Pte. Ltd.Singapore, Singapore1 insp.
Vantive Manufacturing (Thailand) CompanyPluak Daeng, Thailand1 insp.
Nephron SC, LLCWest Columbia, United States1 insp.
Takeda Pharmaceutical Company LimitedHikari, Japan1 insp.
Co-investigators
Investigators who share inspections with this person.
Joey V Quitania4 shared
Wayne D Mcgrath2 shared
Tamil Arasu2 shared
Veronica Fuentes2 shared
Eric L Scott2 shared
Aaron J Poloni2 shared
Jonathan T Little2 shared
Edmund F Mrak2 shared
Margo.C.L. Jones2 shared
John A Gonzalez2 shared
Full investigator report
Get the verbatim findings behind David J Gomes' 119 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site